A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...

Xoma Royalty is acquiring the pharmaceutical company Generation Bio. Xoma, a biotechnology-royalty aggregator, said Monday that it would pay roughly $4.29 a share for the company.

Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna -- Generation ...

XOMA Royalty (XOMA) has entered into an agreement to acquire Generation Bio (GBIO) for a cash price of $4.2913 per share. Generation Bio stockholders also will ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The U.S. Food and Drug Administration has no plans to put a "black box" warning on COVID-19 vaccines, Bloomberg News reported ...

Option traders moderately bearish in Moderna (MRNA), with shares down 12c near $29.34. Options volume relatively light with 19k contracts traded ...

NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...

People familiar with the plan told CNN the FDA is weighing whether to place a black box warning on COVID vaccines. These ...

Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...

NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial Virus Vaccine)mNEXSPIKE will be available in the E ...